2017
DOI: 10.1016/j.meegid.2017.07.023
|View full text |Cite
|
Sign up to set email alerts
|

The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 23 publications
1
18
0
Order By: Relevance
“…Numerous reports indicated that the unfavorable IFNL3 and IFNL4 genotypes are associated with reduced response to pegIFN‐α/RBV therapy and augmented the frequency of HCV infection in PBMCs . The impact of IFNL3 rs12979860 genotypes on OCI is controversial.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Numerous reports indicated that the unfavorable IFNL3 and IFNL4 genotypes are associated with reduced response to pegIFN‐α/RBV therapy and augmented the frequency of HCV infection in PBMCs . The impact of IFNL3 rs12979860 genotypes on OCI is controversial.…”
Section: Discussionmentioning
confidence: 99%
“…All selected patients were genotyped for the SNPs of the IFNL3 gene (rs12979860, rs8099917, and rs12980275) and IFNL4 ss469415590 polymorphism using polymerase chain reaction–restriction fragment length polymorphism (PCR‐RFLP) and TaqMan® Real‐Time SNP Assays, respectively, as previously described …”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations